Acute disseminated encephalomyelitis epidemiology and demographics
Acute disseminated encephalomyelitis Microchapters |
Differentiating Acute disseminated encephalomyelitis from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Acute disseminated encephalomyelitis epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Acute disseminated encephalomyelitis epidemiology and demographics |
FDA on Acute disseminated encephalomyelitis epidemiology and demographics |
CDC on Acute disseminated encephalomyelitis epidemiology and demographics |
Acute disseminated encephalomyelitis epidemiology and demographics in the news |
Blogs on Acute disseminated encephalomyelitis epidemiology and demographics |
Directions to Hospitals Treating Acute disseminated encephalomyelitis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Epidemiology and Demographics
Incidence
- The Incidence of Acute disseminated encephalomyelitis is about 1 in 125,000-250,000 people each year, in children younger than 10 years, despite the fact that it is a rare disorder.
- Each year, regional medical centers in the United States, the United Kingdom, and Australia see three to six instances.
Prevalence
- There is no data on the prevalence of Acute disseminated encephalomyelitis.
Case-fatality rate/Mortality rate
- The mortality rate of retinoblastoma differs according to the stage of the disease as well as the geographic region.[1]
- In extraocular form of this disorder is reported to be greater than 50%.[2]
- However, tumors involving the optic disc superficially, are associated with 10% mortality rate.[3]
Age
- In youngsters, the usual age of onset is 3 to 7 years.
- Cases have also been reported in children between the ages of 10 and twenty.
- Adults between the ages of 18 and 82 are also affected.[4]
Gender
Race
Region
- Epidemiological data indicates that retinoblastoma has a higher incidence in some geographic areas.[6]
- The table below provides the highest worldwide incidence rate of retinoblastoma in children aged 0 - 4:
References
- ↑ Dimaras, Helen; Kimani, Kahaki; Dimba, Elizabeth AO; Gronsdahl, Peggy; White, Abby; Chan, Helen SL; Gallie, Brenda L (2012). "Retinoblastoma". The Lancet. 379 (9824): 1436–1446. doi:10.1016/S0140-6736(11)61137-9. ISSN 0140-6736.
- ↑ Kim, J W; Kathpalia, V; Dunkel, I J; Wong, R K; Riedel, E; Abramson, D H (2008). "Orbital recurrence of retinoblastoma following enucleation". British Journal of Ophthalmology. 93 (4): 463–467. doi:10.1136/bjo.2008.138453. ISSN 0007-1161.
- ↑ Chévez-Barrios, Patricia; Eagle, Ralph C.; Marback, Eduardo F. (2015). "Histopathologic Features and Prognostic Factors": 167–183. doi:10.1007/978-3-662-43451-2_16.
- ↑ "StatPearls". 2021. PMID 28613684.
- ↑ 5.0 5.1 Abramson DH, Frank CM, Susman M, Whalen MP, Dunkel IJ, Boyd NW (1998). "Presenting signs of retinoblastoma". J Pediatr. 132 (3 Pt 1): 505–8. PMID 9544909.
- ↑ Singh, Arun (2007). Clinical ophthalmic oncology. Edinburgh: Elsevier Saunders. ISBN 978-1-4160-3167-3.